Angelo Armandi

3.2k total citations
86 papers, 828 citations indexed

About

Angelo Armandi is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Angelo Armandi has authored 86 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 29 papers in Hepatology and 21 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Angelo Armandi's work include Liver Disease Diagnosis and Treatment (57 papers), Diet, Metabolism, and Disease (19 papers) and Inflammatory Bowel Disease (15 papers). Angelo Armandi is often cited by papers focused on Liver Disease Diagnosis and Treatment (57 papers), Diet, Metabolism, and Disease (19 papers) and Inflammatory Bowel Disease (15 papers). Angelo Armandi collaborates with scholars based in Italy, Germany and Belarus. Angelo Armandi's co-authors include Elisabetta Bugianesi, Gian Paolo Caviglia, Chiara Rosso, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Jörn M. Schattenberg, Antonella Olivero, Maria Lorena Abate, Marco Astegiano and Rinaldo Pellicano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Scientific Reports.

In The Last Decade

Angelo Armandi

75 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angelo Armandi Italy	16	517	194	194	169	146	86	828
Oriol Juanola Spain	15	417 0.8×	101 0.5×	192 1.0×	132 0.8×	298 2.0×	22	756
Saeed Esmaili Australia	13	792 1.5×	234 1.2×	351 1.8×	158 0.9×	139 1.0×	19	963
Paula Iruzubieta Spain	19	554 1.1×	197 1.0×	250 1.3×	101 0.6×	177 1.2×	68	912
Ibrahim Ayada Netherlands	12	393 0.8×	163 0.8×	151 0.8×	65 0.4×	103 0.7×	21	548
Christine Carter‐Kent United States	10	972 1.9×	475 2.4×	340 1.8×	120 0.7×	126 0.9×	13	1.1k
Giuseppe Marrone Italy	17	464 0.9×	135 0.7×	258 1.3×	173 1.0×	204 1.4×	50	853
Enver Dolar Türkiye	15	476 0.9×	199 1.0×	189 1.0×	52 0.3×	177 1.2×	53	943
Tommy Pacana United States	9	577 1.1×	235 1.2×	162 0.8×	127 0.8×	202 1.4×	20	848
Aloysious Aravinthan United Kingdom	16	423 0.8×	62 0.3×	270 1.4×	270 1.6×	248 1.7×	40	1.0k
Daniel Contaifer United States	13	336 0.6×	146 0.8×	88 0.5×	111 0.7×	181 1.2×	22	700

Countries citing papers authored by Angelo Armandi

Since Specialization

Citations

This map shows the geographic impact of Angelo Armandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Armandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Armandi more than expected).

Fields of papers citing papers by Angelo Armandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Armandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Armandi. The network helps show where Angelo Armandi may publish in the future.

Co-authorship network of co-authors of Angelo Armandi

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Armandi. A scholar is included among the top collaborators of Angelo Armandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Armandi. Angelo Armandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferro, Arianna, Gian Paolo Caviglia, Chiara Rosso, et al.. (2025). Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease and Associated Comorbidities on Cognitive and Health-Related Quality-of-Life Outcomes in a Mixed Metabolic Dysfunction-Associated Steatotic Liver Disease-Type 2 Diabetes Mellitus Cohort. The American Journal of Gastroenterology. 120(8). 1779–1790.

Bertani, Lorenzo, Davide Giuseppe Ribaldone, Fabrizio Bossa, et al.. (2025). When to Switch to Subcutaneous Infliximab? The RE-WATCH Multicenter Study. Inflammatory Bowel Diseases. 31(12). 3363–3369.

Tovo, Pier‐Angelo, Angelo Armandi, M. Bruno, et al.. (2025). Adults with celiac disease exhibit overexpression of endogenous retroviruses, TRIM28, and SETDB1 despite gluten-free diet. Virus Research. 359. 199613–199613.

Pugliese, Nicola, Davide Polverini, Rosa Lombardi, et al.. (2024). Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility. Journal of Personalized Medicine. 14(6). 568–568. 6 indexed citations

Rosso, Chiara, Gian Paolo Caviglia, Angelo Armandi, et al.. (2024). Response to a 6-month personalized dietary intervention in patients with metabolic dysfunction-associated steatotic liver disease. Digestive and Liver Disease. 56. S55–S55.

Cusato, Jessica, Alessandra Manca, Gian Paolo Caviglia, et al.. (2024). Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease. Biomedicines. 12(2). 320–320. 4 indexed citations

Michel, Maurice Stephan, Michelle Doll, Saleh A. Alqahtani, et al.. (2024). Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis. Scientific Reports. 14(1). 21650–21650. 1 indexed citations

Armandi, Angelo & Elisabetta Bugianesi. (2024). Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease. European Journal of Internal Medicine. 122. 20–27. 27 indexed citations

Armandi, Angelo, Chiara Rosso, Gian Paolo Caviglia, & Elisabetta Bugianesi. (2024). An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance. Metabolism. 162. 156080–156080. 10 indexed citations

10.

Armandi, Angelo & Elisabetta Bugianesi. (2023). Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease. 27(2). 239–250. 9 indexed citations

11.

Armandi, Angelo, Gian Paolo Caviglia, Amina Abdulle, et al.. (2023). Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease. Cancers. 15(6). 1659–1659. 4 indexed citations

12.

D’Ascenzo, Fabrizio, Francesco Bruno, Mario Iannaccone, et al.. (2023). Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis. International Journal of Cardiology. 378. 96–104. 20 indexed citations

13.

Armandi, Angelo, Chiara Rosso, Ramy Younes, et al.. (2023). Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine. 12(2). 650–650. 6 indexed citations

14.

Petroni, Maria Letizia, et al.. (2023). Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs. Nutrients. 15(3). 792–792. 9 indexed citations

15.

Ribaldone, Davide Giuseppe, Sophie Vieujean, Mette Julsgaard, et al.. (2023). Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series. Journal of Crohn s and Colitis. 17(7). 1097–1102. 1 indexed citations

16.

Petroni, Maria Letizia, Santo Colosimo, Lucia Brodosi, et al.. (2023). Long‐term follow‐up of web‐based and group‐based behavioural intervention in NAFLD in a real world clinical setting. Alimentary Pharmacology & Therapeutics. 59(2). 249–259. 4 indexed citations

17.

Rosso, Chiara, et al.. (2023). Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD. Nutrients. 15(13). 3018–3018. 6 indexed citations

18.

Armandi, Angelo, Chiara Rosso, Gian Paolo Caviglia, et al.. (2022). Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine. 11(3). 635–635. 18 indexed citations

19.

Saponaro, Chiara, Silvia Sabatini, Melania Gaggini, et al.. (2022). Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals. Liver International. 42(11). 2418–2427. 64 indexed citations

20.

Caviglia, Gian Paolo, Chiara Rosso, Angelo Armandi, et al.. (2020). Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P. International Journal of Molecular Sciences. 21(22). 8838–8838. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact